Short-course radiotherapy is not optimal for spinal cord compression due to myeloma
Creators
- 1. Department of Radiation Oncology, University Hospital, Hamburg (Germany) and Department of Radiation Oncology, Medical School, Hannover (Germany)
- 2. Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex (United Kingdom)
- 3. Department of Radiotherapy, Academic Medical Center, Amsterdam (Netherlands)
- 4. Department of Radiation Oncology, University Hospital, Lubeck (Germany)
- 5. Department of Radiation Oncology, Dr. Bernard Verbeeten Institute, Tilburg (Netherlands)
- 6. Institute of Radiobiology, University Hospital Eppendorf, Hamburg (Germany)
- 7. Department of Radiotherapy, University Hospital, Sarajevo (Bosnia and Herzegowina)
- 8. Department of Radiotherapy, Siloah Hospital, Hannover (Germany)
- 9. Department of Radiotherapy, St. Georg Hospital, Hamburg (Germany)
- 10. Department of Radiation Oncology, Philipps-University, Marburg (Germany)
- 11. Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ (United States)
Description
Purpose: To investigate the suitability of short-course radiotherapy (RT) for spinal cord compression (SCC) in myeloma patients. Methods and Materials: Data for 172 myeloma patients irradiated between January 1994 and December 2004 for SCC were retrospectively evaluated. Short-course RT (1 x 8 Gy, 5 x 4 Gy, n = 61) and long-course RT (10 x 3 Gy, 15 x 2.5 Gy, 20 x 2 Gy, n = 111) were compared for functional outcome up to 24 months after RT. In addition, 10 potential prognostic factors were investigated. Results: Improvement of motor function occurred in 90 patients (52%). Forty-seven percent of nonambulatory patients regained the ability to walk. Functional outcome was significantly influenced by the time of developing motor deficits before RT. Improvement of motor function was more frequent after long-course RT than after short-course RT: 59% vs. 39% (p = 0.10) at 1 month, 67% vs. 43% (p 0.043) at 6 months, 76% vs. 40% (p = 0.003) at 12 months, 78% vs. 43% (p 0.07) at 18 months, and 83% v 54% (p = 0.33) at 24 months. A subgroup analysis of the long-course RT group demonstrated a similar functional outcome for 10 x 3 Gy when compared with 15 x 2.5 Gy and 20 x 2 Gy. Conclusions: Long-course RT is preferable for SCC in myeloma patients because it resulted in better functional outcome than short-course RT. Treatment with 10 x 3 Gy can be considered appropriate
Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2005.10.018;
- PII
- S0360-3016(05)02831-2;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 64
- Journal Issue
- 5
- Journal Page Range
- p. 1452-1457
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 37095070
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CENTRAL NERVOUS SYSTEM; IRRADIATION; NERVOUS SYSTEM DISEASES; PATIENTS; RADIOTHERAPY; SPINAL CORD
- Descriptors DEC
- CENTRAL NERVOUS SYSTEM; DISEASES; MEDICINE; NERVOUS SYSTEM; NUCLEAR MEDICINE; RADIOLOGY; THERAPY
Optional Information
- Copyright
- Copyright (c) 2006 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.